$55.21
6.25% yesterday
NYSE, May 12, 10:19 pm CET
ISIN
US4330001060
Symbol
HIMS

Hims & Hers Health Inc. Target price 2025 - Analyst rating & recommendation

Hims & Hers Health Inc. Classifications & Recommendation:

Buy
31%
Hold
56%
Sell
13%

Hims & Hers Health Inc. Price Target

Target Price $46.20
Price $55.21
Deviation
Number of Estimates 15
15 Analysts have issued a price target Hims & Hers Health Inc. 2026 . The average Hims & Hers Health Inc. target price is $46.20. This is lower than the current stock price. The highest price target is , the lowest is .
A rating was issued by 16 analysts: 5 Analysts recommend Hims & Hers Health Inc. to buy, 9 to hold and 2 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Hims & Hers Health Inc. stock has an average upside potential 2026 of . Most analysts recommend the Hims & Hers Health Inc. stock at Hold.

Sales and Margin forecast 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Billion $ 1.48 2.35
69.32% 58.88%
EBITDA Margin 5.76% 13.58%
309.82% 135.64%
Net Margin 8.03% 6.15%
384.55% 23.37%

15 Analysts have issued a sales forecast Hims & Hers Health Inc. 2025 . The average Hims & Hers Health Inc. sales estimate is

$2.3b
Unlock
. This is
31.47% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$2.4b 34.06%
Unlock
, the lowest is
$2.3b 29.13%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $1.5b 69.32%
2025
$2.3b 58.88%
Unlock
2026
$2.9b 21.91%
Unlock
2027
$3.5b 22.42%
Unlock
2028
$4.2b 19.39%
Unlock
2029
$5.0b 19.54%
Unlock

15 Analysts have issued an Hims & Hers Health Inc. EBITDA forecast 2025. The average Hims & Hers Health Inc. EBITDA estimate is

$319m
Unlock
. This is
130.99% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$341m 147.54%
Unlock
, the lowest is
$296m 114.90%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 $85.1m 455.28%
2025
$319m 274.43%
Unlock
2026
$419m 31.50%
Unlock
2027
$537m 28.08%
Unlock
2028
$676m 26.06%
Unlock
2029
$855m 26.41%
Unlock

EBITDA Margin

2024 5.76% 309.82%
2025
13.58% 135.64%
Unlock
2026
14.65% 7.88%
Unlock
2027
15.33% 4.64%
Unlock
2028
16.18% 5.54%
Unlock
2029
17.11% 5.75%
Unlock

13 Hims & Hers Health Inc. Analysts have issued a net profit forecast 2025. The average Hims & Hers Health Inc. net profit estimate is

$144m
Unlock
. This is
6.44% lower
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$217m 40.98%
Unlock
, the lowest is
$78.3m 49.28%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $118m 581.82%
2025
$144m 21.81%
Unlock
2026
$214m 48.23%
Unlock
2027
$283m 32.23%
Unlock
2028
$272m 3.99%
Unlock
2029
$352m 29.63%
Unlock

Net Margin

2024 8.03% 384.55%
2025
6.15% 23.37%
Unlock
2026
7.48% 21.63%
Unlock
2027
8.08% 8.02%
Unlock
2028
6.50% 19.55%
Unlock
2029
7.05% 8.46%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share $ 0.53 0.65
581.82% 22.64%
P/E 85.52
EV/Sales 5.16

13 Analysts have issued a Hims & Hers Health Inc. forecast for earnings per share. The average Hims & Hers Health Inc. EPS is

$0.65
Unlock
. This is
5.80% lower
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
$0.97 40.58%
Unlock
, the lowest is
$0.35 49.28%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $0.53 581.82%
2025
$0.65 22.64%
Unlock
2026
$0.96 47.69%
Unlock
2027
$1.27 32.29%
Unlock
2028
$1.22 3.94%
Unlock
2029
$1.58 29.51%
Unlock

P/E ratio

Current 80.36 110.59%
2025
85.52 6.42%
Unlock
2026
57.69 32.54%
Unlock
2027
43.63 24.37%
Unlock
2028
45.44 4.15%
Unlock
2029
35.05 22.87%
Unlock

Based on analysts' sales estimates for 2025, the Hims & Hers Health Inc. stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 6.78 165.88%
2025
5.16 23.94%
Unlock
2026
4.23 17.97%
Unlock
2027
3.46 18.31%
Unlock
2028
2.89 16.24%
Unlock
2029
2.42 16.35%
Unlock

P/S ratio

Current 6.93 151.87%
2025
5.27 23.94%
Unlock
2026
4.32 17.97%
Unlock
2027
3.53 18.31%
Unlock
2028
2.96 16.24%
Unlock
2029
2.47 16.35%
Unlock

Current Hims & Hers Health Inc. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Piper Sandler
Locked
Locked
Locked May 06 2025
Citigroup
Locked
Locked
Locked May 06 2025
Needham
Locked
Locked
Locked May 06 2025
Morgan Stanley
Locked
Locked
Locked Apr 29 2025
TD Cowen
Locked
Locked
Locked Apr 29 2025
B of A Securities
Locked
Locked
Locked Apr 29 2025
Citigroup
Locked
Locked
Locked Apr 25 2025
Analyst Rating Date
Locked
Piper Sandler:
Locked
Locked
May 06 2025
Locked
Citigroup:
Locked
Locked
May 06 2025
Locked
Needham:
Locked
Locked
May 06 2025
Locked
Morgan Stanley:
Locked
Locked
Apr 29 2025
Locked
TD Cowen:
Locked
Locked
Apr 29 2025
Locked
B of A Securities:
Locked
Locked
Apr 29 2025
Locked
Citigroup:
Locked
Locked
Apr 25 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today